Ultralife Corporation
ULBI
$4.13
-$0.15-3.51%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -89.76% | -80.60% | -11.11% | 935.55% | 1,368.75% |
| Total Depreciation and Amortization | 22.05% | 0.71% | 2.94% | -0.31% | -7.12% |
| Total Amortization of Deferred Charges | 193.75% | -25.00% | 0.00% | 0.00% | 45.45% |
| Total Other Non-Cash Items | 48.21% | -80.04% | -35.63% | 443.33% | 400.00% |
| Change in Net Operating Assets | 182.05% | 192.04% | 199.13% | -170.67% | -187.01% |
| Cash from Operations | 25.25% | 633.86% | 409.71% | 94.07% | -5.15% |
| Capital Expenditure | 39.70% | -11.24% | 30.23% | 25.15% | -255.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4,738.61% | -11.24% | 30.23% | 25.15% | -255.12% |
| Total Debt Issued | 5,400.00% | -- | -- | -- | -- |
| Total Debt Repaid | -435.67% | -706.60% | -2,535.80% | 0.00% | 0.00% |
| Issuance of Common Stock | -81.16% | -97.55% | 1,917.74% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 15,276.08% | -267.85% | -863.64% | -89.72% | 80.94% |
| Foreign Exchange rate Adjustments | 87.92% | -25.00% | 61.34% | 293.48% | -272.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -91.81% | -91.75% | -227.30% | -65.74% | 47.58% |